Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13Neoplasms 2Urogenital Neoplasms 1Prostatic Diseases 1Neoplasms, Glandular and Epithelial 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Hormone-Refractory Prostate Cancer 1Genital Neoplasms, Male 1Carcinoma 1Adenocarcinoma of the Prostate 1Adenocarcinoma 1

Interventions

darolutamide 2Abiraterone Acetate 2sipuleucel-T 1onapristone 1olaparib 1niraparib 1luprolide acetate gel depot 1gedatolisib 1gallium 68 PSMA-11 1apalutamide 1abiraterone 1Robotic Surgical Procedures 1Pluvicto 1Paclitaxel 1Lutetium-177 1Lutetium 1Leuprolide 1Imatinib Mesylate 1EPI-506 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Prostatic Diseases × sipuleucel-T × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡